The nucleotide sequence analysis of the dihydropteroate synthase (DHPS) gene of six diaminodiphenylsulfone-resistant Mycobacterium leprae strains revealed that the mutation was limited at highly conserved amino acid residues 53 or 55. Though the mutation at amino acid residue 55 or its homologous site has been reported in other bacteria, the mutation at residue 53 is the first case in bacteria. This is the first paper which links the mutations in DHPS and sulfonamide resistance in M. leprae. This finding is medically and socially relevant, since leprosy is still a big problem in certain regions. ß
Introduction
Most prokaryotes synthesize amino acids and nucleic acids using folate as a coenzyme. Since prokaryotes are unable to take up extracellular folates, they have to synthesize them de novo. Dihydropteroate synthase (DHPS) (EC 2.5.1.15) is a key enzyme involved in the de novo synthesis of folate catalyzing synthesis of 7,8-dihydropteroate from 7,8-dihydropterin-pyrophosphate and para-aminobenzoic acid (PABA) [1] .
Sulfonamide was the ¢rst synthetic antimicrobial agent used for prophylaxis and therapy of bacterial infections and more recently its derivatives, including sulfathiazole, sulfadoxine, and sulfamethoxazole, have been developed. The mode of action of the drug is to inhibit the synthesis of 7,8-dihydropteroate by the competitive incorporation of sulfonamide as the structural analogue of PABA [2] .
Among sulfonamide derivatives, diaminodiphenylsulfone (DDS) has long been used as a ¢rst-line drug worldwide for the treatment of leprosy [3] , which is caused by chronic infection with Mycobacterium leprae. DDS-resistant M. leprae has emerged and it has been reported since the 1950s [4, 5] . Little is known about the molecular mechanism of DDS resistance in M. leprae, in spite of the fact that increasing numbers of DDS-resistant M. leprae have been repeatedly reported. Multidrug chemotherapy of leprosy with DDS, rifampicin, and clofazimine has been rec-ommended by the World Health Organization [6] , yet the problem of DDS resistance had received less attention. Sulfonamide resistance in bacteria has been studied in Streptococcus pneumoniae, Neisseria meningitidis, and Escherichia coli and it has been revealed that genes encoding DHPS had mutations [7^9] .
To explore the molecular mechanism of DDS resistance in medically and socially important M. leprae, we have analyzed the DHPS gene (folP) from DDS-susceptible and -resistant M. leprae.
Materials and methods

Bacterial strains and growth condition
M. leprae was isolated in this laboratory from biopsy samples obtained from the following hospitals: National Leprosarium Zensho-en, Airaku-en, and Shinsei-en, and Kanazawa University of Japan, as listed in Table 1 . Thai-53 was isolated from a patient in Thailand. The strains were established by serial passage of the footpads of athymic nude mice, except Zensho-5 and Shinsei-1. Zensho-5 and Shinsei-1 were fresh isolates.
DDS susceptibility test
Athymic nude mice were inoculated with 10 5^1 0 6 bacilli into the footpad and bacterial suspensions were prepared from footpad homogenate 12 months after inoculation [10] . DDS susceptibility was determined by injecting 1.0U10 4 bacilli per footpad of BALB/c mice, given daily food containing 0.01%, 0.001%, or 0.0001% of DDS for 30 weeks and the growth of the bacteria was scored as described previously [11] . Typically, resistant strains were capable of growing in these mice to approximately 10 6 per footpad, whereas growth of susceptible strains was suppressed in the footpads of mice given daily food containing 0.0001% of DDS.
DNA manipulations
M. leprae was collected from either mouse footpads or human biopsy specimens by the method in [12] , and then DNA was extracted from the mechanically disrupted cells [13] . The recombinant DNA technique is essentially similar to the established method [14] . Brie£y, bacteria were suspended in bu¡er containing 150 mM NaCl, 50 mM Tris-HCl (pH 7.4), 5 mM EDTA, and 5% SDS. The bacterial suspension was frozen in liquid nitrogen and was homogenized with a Polytron. The resultant powder was then extracted with phenol/chloroform and precipitated with ethanol. For sequencing, the DNA fragment containing the folP gene was ampli¢ed by PCR using primers FP-F (5P-GCTTCTCGT-GCCGAAGCGCTCG-3P) and FP-R (5P-CGCAAC-TCCATTCGGTCAGCCATC-3P). The primers were designed for conserved sequences in both M. leprae folP (GenBank accession number AL023093) and M. tuberculosis folP (GenBank accession number Z95557). DNA was ampli¢ed in an automated thermal cycler (GeneAmp PCR System 2400, Perkin-Elmer, Norwalk, CT, USA) at 94³C for 30 s, 60³C for 30 s, and 72³C for 30 s. Reaction was terminated at 35 cycles. The ampli¢ed products were puri¢ed by agarose gel electrophoresis using EasyTrap kit (TaKaRa Shuzo, Shiga, Japan).
DNA sequencing and analysis
The DNA was sequenced by the dideoxy-chain termination method with the ABI Prism BigDye Terminator Cycle Sequencing kit (Perkin-Elmer Applied Biosystems, Norwalk, CT, USA) and an ABI Prism 310 Genetic Analyzer (Perkin-Elmer Applied Biosystems). Computer analysis was carried out using the DNASIS program (Hitachi Software Engineering, Yokohama, Japan), and nucleic acid sequences were compared with those in the GenBank database.
Results
Diaminodiphenylsulfone susceptibility
M. leprae strains were obtained from multibacillary leprosy patients [15] . We tested DDS susceptibility of these strains and found that four out of eight strains were resistant, and both Thai-53 and Kanazawa were susceptible. Two strains, Zensho-5 and Shinsei-1, were presupposed to be DDS-resistant based on clinical data, though the susceptibility test was not done. Three strains, Zensho-2, Airaku-3 and Zensho-4, exhibited high resistance to DDS multiplied in mice given 0.01% of the drug. Strain Airaku-2 was low resistant that multiplied in the mice given 0.0001% of DDS, but not 0.001%.
Ampli¢cation and sequence analysis of the folP gene of M. leprae
The folP gene is located in chromosomal DNA £anked by genes encoding enzymes involved in the folate synthesis pathway. When the M. leprae chromosome was subjected to PCR ampli¢cation using FP-F and FP-R primers, the expected size of products was obtained from all strains. PCR products were sequenced directly by the dideoxy chain termination method. All PCR products contained a fulllength folP gene, 855 bp, including initiation and stop codons. The sequence was compared with the GenBank-DDBJ database using a BLAST program [16] . A part of the folP sequence, in which the mutations were located, is shown in Fig. 1 . Four resistant strains, Zensho-2, Zensho-4, Airaku-2, and Airaku- 3, had a C to T substitution at nucleotide 158 or 164 and the rest of the nucleotide sequence was identical to that of the wild-type folP except that in Zensho-2 (see below). The sequences of folP from two DDSsusceptible strains were identical to those in the database (Table 1) . Zensho-5 and Shinsei-1, which were not subjected to the drug susceptibility test, showed C to T and A to G substitutions, at nucleotides 164 and 157, respectively. Zensho-2 showed two mutations, a C to T transition at 87 and 164. However, the mutation at position 87 may encode the same amino acid to the wild-type DHPS, and therefore, the mutation in the amino acid sequence is Pro55Leu only. The mutations at nucleotides 157, 158, and 164 would substitute Pro to Leu at amino acid residue 55 and Thr to Ile or Ala at residue 53 of DHPS, respectively. In spite of the fact that the resistant strains were originally isolated from di¡erent geographical locations in Japan (Table 1) , the mutation was found at the same codon. The amino acid sequence of DHPS relevant to the mutations found in this study was compared with that of E. coli, Streptococcus pyogenes, and N. meningitidis ( Table 2 ). The resistant E. coli and N. meningitidis had a mutation corresponding to amino acid residue 55 of the M. leprae DHPS [9, 17] .
Discussion
Studies on sulfonamide resistance in a few species of microorganisms have revealed that the mutations occurred in the folP gene encoding DHPS [8, 9, 17] . The sulfonamide-resistant S. pyogenes and N. meningitidis had the folP gene with approximately 10% altered nucleotide residues as compared with that in the wild-type strains. In contrast, the laboratoryisolated E. coli mutants resistant to sulfonamide showed only a single amino acid substitution, Pro-64 of DHPS to Ser [9] . Among the mutations in the N. meningitidis DHPS, one was located at position 64. However, this was not the case in the mutant DHPS from S. pyogenes. We discovered, for the ¢rst time, two independent sites of mutations in the folP of DDS-resistant M. leprae. As mentioned above, clinical isolates of S. pyogenes and N. meningitidis accumulated many mutations, but clinical isolates of M. leprae had only a single amino acid change. This might be due to a unique feature of the M. leprae chromosome, which shows low diversity of DNA sequence [18] .
The X-ray crystallographic structural analysis of the E. coli DHPS has shown that Arg-63 and Lys-221 form the PABA and sulfonamide binding sites [19] . Arg-63 of the E. coli DHPS is assumed to function similarly to Arg-54 of the M. leprae DHPS. Mutation in either Thr-53 or Pro-55 was assumed to cause a three-dimensional conformation change of Arg-54 reducing the binding capability of DHPS with sulfonamide. Although the mutation at position 55 of M. leprae and the corresponding sites in E. coli and N. meningitidis was found, the mutation at 53 was only found in M. leprae DHPS. It was reported that Plasmodium falciparum DHPS had a mutation at an analogous site to Thr-53 of M. leprae [20] . Since it is highly conceivable that Arg-54 of the M. leprae DHPS may play a role in DDS binding, we assume that both mutations Thr-53 and Pro-55 are involved in the resistance. However, we found no signi¢cant linkage between the location of the mutation and the degree of resistance (Table 1) . To explore the linkage between the mutation in the folP gene and a speci¢c sulfonamide resistance in M. leprae, further studies are needed.
Our result revealed that two distinct mutations in the folP gene are involved in DDS resistance in leprosy bacilli. This ¢nding is medically relevant, since the option of chemotherapeutic agents is limited for the treatment of leprosy infection. This result may be readily applicable to rapid diagnosis of DDS-resistant M. leprae.
